Tenders/Medicines Used in Blood Disorders
Awarded🇨🇱ChileSuppliesThis tender has expired

Medicines Used in Blood Disorders

Auto-translated from Spanish
Original title: Medicamentos Usados en Trastornos Sanguíneos
Published: Mar 7, 2026
Updated: Jun 20, 2026
Source: chile_mercadopublico

This tender has been awarded

Awarded to LABORATORIOS ANDROMACO S.A. — CLP 130,084,200

Browse open Health & Medical tenders in Chile

About This Opportunity

Translated

This tender concerns the procurement of medicines specifically intended for the treatment of blood disorders. The scope of the tender involves supplying a range of pharmaceutical products essential for managing various hematological conditions. While specific details regarding the exact types and quantities of medicines required are not provided in this initial description, the focus is clearly on specialized treatments for blood-related ailments. Potential bidders are expected to be pharmaceutical suppliers or manufacturers capable of providing high-quality, registered medicines that meet stringent regulatory standards. The tender likely entails a competitive bidding process where suppliers will be evaluated based on factors such as product quality, price, delivery timelines, and compliance with relevant pharmaceutical regulations. Further details regarding the specific list of medicines, quantities, delivery locations, and evaluation criteria will be outlined in the full tender documentation. This procurement is crucial for ensuring the availability of essential treatments for patients suffering from blood disorders, contributing to the overall healthcare infrastructure and patient well-being. Interested parties should prepare to submit comprehensive proposals that demonstrate their capacity to meet the specified requirements for these critical medical supplies.

This is a supplies contract in the health and medical services, transport and logistics and trade and industry sectors, with a focus on Pharmaceuticals, Logistics and Manufacturing. Located in Chile, Latin America, this opportunity is open to firms and consortiums.

Published through Chile Mercado Publico, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.

Description

Original language: Spanish

This tender, published by the Chilean government via the Mercado Público platform, seeks the supply of Medicamentos Usados en Trastornos Sanguíneos (Medications Used in Blood Disorders). The contracting authority is seeking to procure a range of pharmaceutical products essential for the treatment and management of various hematological conditions.

This procurement process is critical for ensuring the availability of vital medications for patients within the Chilean public health system.

The scope of this tender will likely encompass the supply of a diverse portfolio of drugs, potentially including but not limited to, hematopoietic growth factors, anticoagulants, antiplatelet agents, iron chelators, immunosuppressants, and other specialized therapies.

Interested suppliers are expected to demonstrate their capacity to provide high-quality, registered pharmaceutical products that meet stringent regulatory standards.

Typical requirements for such tenders include detailed product specifications, evidence of Good Manufacturing Practice (GMP) compliance, valid marketing authorizations from relevant health authorities, and a robust supply chain management system to guarantee timely and consistent delivery across Chile. Bidders will also need to provide comprehensive commercial proposals, including pricing, delivery terms, and after-sales support. Experience in supplying to public health institutions and adherence to ethical marketing practices are often key evaluation criteria. This opportunity represents a significant contract for pharmaceutical manufacturers and distributors with a presence or interest in the South American market.

Data provenance

This notice is sourced from Chile Mercado Publico and was originally published on March 7, 2026. Last refreshed 26 days ago. Original language: Spanish. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

Frequently asked questions about this tender

Is this tender still open?

No — the contract has already been awarded to LABORATORIOS ANDROMACO S.A.. The award notice is archived on BidsFactory for transparency and market intelligence.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

How much was the contract awarded for?

LABORATORIOS ANDROMACO S.A. was awarded the contract for CLP 130,084,200. The figure reflects the value disclosed by the contracting authority in the award notice.

Where will the contract be performed?

The contract is for delivery in Chile. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.

How can I submit a bid?

Visit Chile Mercado Publico to access the full notice, required documents, and submission instructions provided by the contracting authority.

Find tenders like this automatically

Set up alerts and filters that match your business — never miss a relevant opportunity again.

See plans

Key Details

Submission Deadline
Feb 11, 2026
Deadline passed
Contract Type
Supplies
Eligibility
Firms / Consortiums
Language
Spanish

Source

chile_mercadopublico
chile_mercadopublico
Official Source

Matching Experts

Are you a consultant?

Join our Expert Network and get matched with relevant tenders.